Venous Thromboembolism Risk Low in COVID-19 Outpatients

MONDAY, March 20, 2023 (HealthDay News) -- The absolute risk for venous thromboembolism (VTE) is low among outpatients with COVID-19, according to a study published online March 13 in JAMA Network Open.
Margaret C. Fang, M.D., from the University of California in San Francisco, and colleagues assessed the risk for VTE among outpatients with COVID-19. The analysis included data from 398,530 outpatients identified from the Kaiser Permanente Virtual Data Warehouse and electronic health records (Jan. 1, 2020, to Jan. 31, 2021).
The researchers found that 0.1 percent of patients had a VTE event during the study period. The sharpest increase in VTE risk occurred during the first 30 days after COVID-19 diagnosis (unadjusted rate, 0.58 versus 0.09 after 30 days). Risk factors for VTE among COVID-19 outpatients included age 55 to 64 years (hazard ratio [HR], 1.85), 65 to 74 years (HR, 3.43), 75 to 84 years (HR, 5.46), and 85 years and older (HR, 6.51); male gender (HR, 1.49); prior VTE (HR, 7.49); thrombophilia (HR, 2.52); inflammatory bowel disease (HR, 2.43); body mass index of 30.0 to 39.9 kg/m² (HR, 1.57); and body mass index ≥40.0 kg/m² (HR, 3.07).
"These findings may help identify subsets of patients with COVID-19 who may benefit from more intensive surveillance or VTE preventive strategies," the authors write.
Related Posts
FDA Approves Lynparza for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
TUESDAY, June 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...
Health Highlights: Feb. 16, 2022
CDC may soon move to ease recommendations on masks. The agency is expected to...
Breast Self-Exam
Why do I need to examine my breasts?The short answer is that you may not have...
Science Brings New Insight Into Origins of OCD
FRIDAY, June 30, 2023 (HealthDay News) -- California psychiatrist Dr. Carolyn...